Leveraging natural language processing to aggregate field safety notices of medical devices across the EU.

NPJ Digit Med

Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.

Published: December 2024

The European Union (EU) Medical Device Regulation and In Vitro Medical Device Regulation have introduced more rigorous regulatory requirements for medical devices, including new rules for post-market surveillance. However, EU market vigilance is limited by the absence of harmonized reporting systems, languages and nomenclatures among Member States. Our aim was to develop a framework based on Natural Language Processing capable of automatically collecting publicly available Field Safety Notices (FSNs) reporting medical device problems by applying web scraping to EU authority websites, to attribute the most suitable device category based on the European Medical Device Nomenclature (EMDN), and to display processed FSNs in an aggregated way to allow multiple queries. 65,036 FSNs published up to 31/12/2023 were retrieved from 16 EU countries, of which 40,212 (61.83%) were successfully assigned the proper EMDN. The framework's performance was successfully tested, with accuracies ranging from 87.34% to 98.71% for EMDN level 1 and from 64.15% to 85.71% even for level 4.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11618595PMC
http://dx.doi.org/10.1038/s41746-024-01337-9DOI Listing

Publication Analysis

Top Keywords

medical device
16
natural language
8
language processing
8
field safety
8
safety notices
8
medical devices
8
device regulation
8
medical
6
device
5
leveraging natural
4

Similar Publications

Vertebral collapse (VC) following osteoporotic vertebral compression fracture (OVCF) often requires aggressive treatment, necessitating an accurate prediction for early intervention. This study aimed to develop a predictive model leveraging deep neural networks to predict VC progression after OVCF using magnetic resonance imaging (MRI) and clinical data. Among 245 enrolled patients with acute OVCF, data from 200 patients were used for the development dataset, and data from 45 patients were used for the test dataset.

View Article and Find Full Text PDF

Electrical excitability of neuronal networks based on the voltage threshold of electrical stimulation.

Sci Rep

December 2024

State Key Laboratory of Digital Medical Engineering, Southeast University, Nanjing, 210096, China.

Microelectrode arrays (MEAs) have been widely used in studies on the electrophysiological features of neuronal networks. In classic MEA experiments, spike or burst rates and spike waveforms are the primary characteristics used to evaluate the neuronal network excitability. Here, we introduced a new method to assess the excitability using the voltage threshold of electrical stimulation.

View Article and Find Full Text PDF

Prognostic role of aetiological agent vs. clinical pattern in candidates to lead extraction for cardiac implantable electronic device infections.

Sci Rep

December 2024

Department of Medical and Surgical Sciences, Institute of Cardiology, University of Bologna, Policlinico S.Orsola-Malpighi, via Massarenti 9, Bologna, 40138, Italy.

Cardiac implantable electronic devices infections (CIEDI) are associated with poor survival despite the improvement in transvenous lead extraction (TLE). Aetiology and systemic involvement are driving factors of clinical outcomes. The aim of this study was to explore their contribute on overall mortality.

View Article and Find Full Text PDF

Introduction: Insecticide-treated bed nets are often used as a physical barrier to prevent infection of malaria. In Sub-Saharan Africa, one of the most important ways of reducing the malaria burden is the utilization of insecticide-treated bed nets. However, there is no sufficient information on the utilization of insecticide-treated bed nets and their associated factors in Ethiopia.

View Article and Find Full Text PDF

BAY 2413555 is a novel selective and reversible positive allosteric modulator of the type 2 muscarinic acetylcholine (M2) receptor, aimed at enhancing parasympathetic signaling and restoring cardiac autonomic balance for the treatment of heart failure (HF). This study tested the safety, tolerability and pharmacokinetics of this novel therapeutic option. REMOTE-HF was a multicenter, double-blind, randomized, placebo-controlled, phase Ib dose-titration study with two active arms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!